Results 61 to 70 of about 155,038 (165)

Global Disparities in the Characteristics and Outcomes of Leukemia Clinical Trials: A Cross-Sectional Study of the ClinicalTrials.gov Database

JCO Global Oncology
PURPOSE Most clinical trials are conducted exclusively in high-income countries (HICs), with only a small fraction involving centers from low-middle income countries (LMICs). However, studies evaluating the global distribution of clinical trials in leukemia are limited.
Abdulrahman Alhajahjeh, Lara K. Rotter, Jessica M. Stempel, Alyssa A. Grimshaw, Jan Philipp Bewersdorf, Ondrej Blaha, Tariq Kewan, Nikolai A. Podoltsev, Rory M. Shallis, Lourdes Mendez, Maximilian Stahl, Amer M. Zeidan   +11 more
openaire   +3 more sources

Menin inhibitor DS-1594b drives differentiation and induces synergistic lethality in combination with venetoclax in acute myeloid leukemia cells with rearranged mixed-lineage leukemia and mutated nucleophosmin-1

Haematologica
Mixed-lineage leukemia (MLL) rearrangements and Nucleophosmin-1 (NPM1) mutations are associated with acute leukemias whose pathogenesis is critically influenced by protein-protein interactions between menin and MLL.
Valerio Ciaurro, Vassilena Sharlandjieva, Anna Skwarska, Catherine Chahrour, Natalia Baran, Zhihong Zeng, Cassandra Ramage, Naval Daver, Bing Z. Carter, Sovira Chaundhry, Palaniraja Thandapani, Maria Paola Martelli, Thomas A. Milne, Marina Konopleva   +13 more
doaj   +1 more source

Iron oxide nanoparticles in leukemia: design, diagnostic applications, and therapeutic strategies

Journal of the Egyptian National Cancer Institute
Leukemia, a heterogeneous group of hematologic malignancies, poses significant challenges in terms of early diagnosis and effective treatment. Recent advancements in nanotechnology have paved the way for innovative approaches in leukemia management, with
Henry Fenekansi Kiwumulo, Haruna Muwonge, Michael Lubwama, Charles Ibingira, John Baptist Kirabira, Robert Tamale Ssekitoleko, Stephen Evans   +6 more
doaj   +1 more source

B10 | HEPTA-REFRACTORY MULTIPLE MYELOMA: BIOLOGY, PROGNOSIS, AND TREATMENT

Haematologica
Introduction. Despite major therapeutic advances, including T-cell–engaging therapies, most patients with multiple myeloma (MM) eventually relapse. An increasing number of patients are presenting with disease refractory to CD38-targeting antibodies, two
C. Riedhammer, M. Truger, H. Lee, L.B. Leypoldt, M. Meggendorfer, S. Hutter, H. Müller, J. Mersi, S.K. Kadel, T. Buchwald, R. Kosch, M. Helal, N. Afrin, A. Rosenwald, E. Gerhard-Hartmann, A. Brioli, J. Krönke, T. Haferlach, C. Haferlach, K.C. Weisel, P. Neri, H. Einsele, K.M. Kortüm, J.M. Waldschmidt, N. Bahlis, N. Weinhold, L. Rasche   +26 more
doaj   +1 more source

POST-TRAUMATIC GROWTH IN MOTHERS OF CHILDREN WITH LEUKEMIA: A CROSS-SECTIONAL STUDY

Nursing and Midwifery Journal, 2022
Naier Moharrami, Mahnaz Jabraeili, Mahni Rahkar Farshi   +2 more
openaire   +1 more source

Burden of acute lymphoblastic leukemia in children and adolescents in low- and middle-income countries from 1990 to 2023 and projections to 2050: A systematic analysis from the global burden of disease study 2023. [PDF]

PLoS One
Liu P, Xu Z, Song W, Yang J, Li J.
europepmc   +1 more source

Hairy Cell Leukemia: A Rare Differential for an Infiltrative Pancreatic Mass. [PDF]

ACG Case Rep J
Ibrahim S, Rabeeah S, Aggarwal N, Kiros N, Jamil L.   +4 more
europepmc   +1 more source

Potential of extracellular vesicle-derived microRNAs as a platform for biomarker discovery in acute lymphoblastic leukemia. [PDF]

PLoS One
Gim JA, Kwak K, Park Y, Kim BS, Kang KW.
europepmc   +1 more source

Treatment outcomes of acute leukemia during pregnancy at the National Institute of Hematology and Blood Transfusion. [PDF]

Leuk Res Rep
Khanh BQ, Son NH, Nhat NQ, Thuy TT, Huong NTM, Chang NT, Thanh NH.   +6 more
europepmc   +1 more source

On mice and humans: the role of thymic stromal lymphopoietin in human B-cell development and leukemia

Haematologica, 2016
Angela Maria Savino, Shai Izraeli
doaj   +1 more source